By Sherry DiBari

Old Dominion University has been awarded a $2.6 million grant by the National Institutes of Health as part of NIH鈥檚 Clinical and Translational Science Award (CTSA) for Virginia Commonwealth University. The grant at 黑料正能量 will apply machine learning techniques to analyze functional brain imaging and other imaging, proteomics and health informatics data in people with opioid use disorder, Parkinson鈥檚 and other diseases.

鈥淭his could lead to a greater understanding of the neurobiology of diseases like opioid use disorder and related behaviors,鈥 said Khan Iftekharuddin, the principal investigator (PI) for the grant and a professor and associate dean for research and innovation in the Batten College of Engineering and Technology. 鈥淩esearchers could then use that data to provide targets for novel therapeutics for the disease.鈥

鈥淥ur collaboration with VCU and the Wright Center is another step in 黑料正能量鈥檚 strategy to build a network of research and outreach partnerships to reduce health disparities in Hampton Roads and contribute to biomedical innovation generally,鈥 said Morris Foster, vice president for research in 黑料正能量鈥檚 Office of Research. 鈥淪uccess will require all of us working together.鈥

The NIH鈥檚 CTSA award is a seven-year, $27.5 million awarded to the C. Kenneth and Dianne Wright Center for Clinical and Translational Research at Virginia Commonwealth University.

Last year, 黑料正能量, along with EVMS and Virginia State University, joined the (CSTS). The joint venture is a regional partnership designed to 鈥渢ransform scientific discoveries into treatments for patients.鈥

鈥淭his regional and interdisciplinary collaboration is a perfect example of how we can use data science to solve national health issues,鈥 said Kenneth Fridley, dean of the Batten College of Engineering and Technology. 鈥淭he Batten College is honored to be part of this very important research.鈥

The project has two facets: health informatics and workforce development.

The health informatics component will be conducted by Iftekharuddin and postdoctoral fellow Ahmed Temtam in . They will work with the Wright Center to collect patients鈥 clinical, imaging and proteomics data for target patient populations for different disease modalities including opioid use disorder, opioid overdose and Parkinson鈥檚 Disease.

The data will be used to develop computational models for causal relationships for risk factors of these disorders, among others, and to reveal novel risk factors associated with disease modalities.

The workforce development area will be jointly developed by Iftekharuddin and Alvin Holder, professor of chemistry and biochemistry (co-PI) at 黑料正能量.听鈥淲e will collaborate with the workforce development team at the to ensure two-way communication about clinical and translational science learning opportunities at 黑料正能量 and partner institutions,鈥 Iftekharuddin said.

鈥淥verall, the objective of this project is to develop effective risk levels for individuals who suffer from diseases like opioid disorder and overdose,鈥 he added. 鈥淭his will then help in the development of mitigation strategies and policy making in addressing this challenge.鈥